NYSE: ANVS
Annovis Bio Inc Stock Ownership - Who owns Annovis Bio?

Insider buying vs selling

Have Annovis Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael B. HoffmanDirector2026-05-2054,933$1.90
$104.37kBuy
Michael B. HoffmanDirector2026-05-202,562$1.75
$4.48kBuy
Michael B. HoffmanDirector2026-05-2018,849$1.80
$33.93kBuy
Michael B. HoffmanDirector2026-04-02713,800$2.10
$1.50MBuy
Michael B. HoffmanDirector2025-12-0830,000$4.34
$130.20kBuy
Michael B. HoffmanDirector2025-12-0815,000$4.24
$63.60kBuy
Michael B. HoffmanDirector2025-11-24415$4.14
$1.72kBuy
Michael B. HoffmanDirector2025-11-2428,096$4.15
$116.60kBuy
Michael B. HoffmanDirector2025-11-241,489$4.13
$6.15kBuy
Michael B. HoffmanDirector2025-11-249,200$3.85
$35.42kBuy

1 of 2

ANVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANVS insiders and whales buy or sell their stock.

ANVS Shareholders

What type of owners hold Annovis Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman8.95%3,811,597$4.19MInsider
Marialuisa MacCecchini2.84%1,212,020$1.33MInsider
Jr Robert M. Whelan0.22%95,700$105.27kInsider
Mark K. White0.14%61,167$67.28kInsider
Jeffrey Brian McGroarty0.12%52,833$58.12kInsider
Claudine Bruck0.03%13,709$15.08kInsider
Reid McCarthy0.02%9,305$10.24kInsider
Empery Asset Management LP0.01%2,401$2.64kInstitution
Empery0.01%2,401$2.64kInstitution
Marshall Wace LLP0.00%1,842$2.03kInstitution

1 of 3

ANVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANVS0.03%12.34%Net Buying
MREO0.01%4.17%
TIL0.00%100.00%
ELTX0.01%43.40%Net Buying
HOWL0.02%83.87%Net SellingNet Selling

Annovis Bio Stock Ownership FAQ

Who owns Annovis Bio?

Annovis Bio (NYSE: ANVS) is owned by 0.03% institutional shareholders, 12.34% Annovis Bio insiders, and 87.63% retail investors. Michael B. Hoffman is the largest individual Annovis Bio shareholder, owning 3.81M shares representing 8.95% of the company. Michael B. Hoffman's Annovis Bio shares are currently valued at $4.35M.

If you're new to stock investing, here's how to buy Annovis Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.